Your browser doesn't support javascript.
loading
Drug survival of the infliximab biosimilar (CT-P13) in paediatric patients with non-infectious uveitis.
Sözeri, Betül; Kardes, Esra; Sali, Enes; Çakir, Deniz; Demir, Ferhat.
Afiliação
  • Sözeri B; Department of Paediatric Rheumatology, Umraniye Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
  • Kardes E; Department of Paediatric Ophthalmology, Umraniye Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
  • Sali E; Department of Paediatric Infectious Diseases, Umraniye Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
  • Çakir D; Department of Paediatric Infectious Diseases, Umraniye Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
  • Demir F; Department of Paediatric Rheumatology, Umraniye Training and Research Hospital, University of Health Sciences, Istanbul, Turkey. drferhat@outlook.com.
Clin Exp Rheumatol ; 39(4): 907-912, 2021.
Article em En | MEDLINE | ID: mdl-33635217
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Uveíte / Preparações Farmacêuticas / Medicamentos Biossimilares Tipo de estudo: Diagnostic_studies / Observational_studies Limite: Aged / Animals / Child / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Uveíte / Preparações Farmacêuticas / Medicamentos Biossimilares Tipo de estudo: Diagnostic_studies / Observational_studies Limite: Aged / Animals / Child / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article